30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

BioDelivery Sciences International Inc (BDSI)

Track

Stock chart
Ticker: BDSI Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Vollins James
See Remarks
1 sale — total 66,748 USD
Planned sale 4 Feb 2022
Value US$1,900,903.36 | Price 263.22 | Shares 4,763
Buy 2 Dec 2021
Value US$4,235,629.88 | Price 433.45 | Shares 8,389
Buy 19 Nov 2021
Value US$306,000.00 | Price 3.06 | Shares 100,000
Buy 12 Nov 2021
Value US$320,000.00 | Price 3.20 | Shares 100,000
Buy 11 Nov 2021
Value US$51,200.00 | Price 3.20 | Shares 16,000
Buy 5 Nov 2021
Value US$894,566.00 | Price 3.47 | Shares 257,800
Buy 13 May 2021
Value US$162,500.00 | Price 3.25 | Shares 50,000
Buy 13 May 2021
Value US$9,480.00 | Price 3.16 | Shares 3,000
Buy 12 May 2021
Value US$324,000.00 | Price 3.24 | Shares 100,000
Buy 12 May 2021
Value US$16,200.00 | Price 3.24 | Shares 5,000
Buy 11 May 2021
Value US$474,000.00 | Price 3.16 | Shares 150,000
Buy 11 May 2021
Value US$23,700.00 | Price 3.16 | Shares 7,500
Planned sale 8 Feb 2021
Value US$15,945.28 | Price 4.16 | Shares 3,833
Planned sale 4 Feb 2021
Value US$32,962.91 | Price 3.97 | Shares 8,303
Planned sale 1 Feb 2021
Value US$13,390.20 | Price 3.87 | Shares 3,460
Planned sale 19 Jan 2021
Value US$27,915.84 | Price 4.32 | Shares 6,462
Sale 16 Dec 2020
Value US$42,582.40 | Price 4.48 | Shares 9,505
Sale 15 Dec 2020
Value US$43,500.00 | Price 4.35 | Shares 10,000
Sale 14 Dec 2020
Value US$90,627.20 | Price 4.46 | Shares 20,320
Sale 18 Aug 2020
Value US$249,500.00 | Price 4.99 | Shares 50,000
Sale 17 Aug 2020
Value US$67,340.00 | Price 5.18 | Shares 13,000
Sale 14 Aug 2020
Value US$563,500.00 | Price 4.90 | Shares 115,000
Sale 13 Aug 2020
Value US$385,050.00 | Price 4.53 | Shares 85,000
Sale 21 May 2020
Value US$99,663.60 | Price 4.60 | Shares 21,666
Planned sale 18 May 2020
Value US$67,800.00 | Price 4.52 | Shares 15,000
Planned sale 8 May 2020
Value US$507,000.00 | Price 5.07 | Shares 100,000
Planned sale 6 May 2020
Value US$50,962.50 | Price 4.53 | Shares 11,250
Planned sale 4 May 2020
Value US$71,200.00 | Price 4.45 | Shares 16,000
Planned sale 27 Apr 2020
Value US$458,000.00 | Price 4.58 | Shares 100,000
Planned sale 20 Apr 2020
Value US$84,400.00 | Price 4.22 | Shares 20,000
Planned sale 15 Apr 2020
Value US$206,500.00 | Price 4.13 | Shares 50,000
Planned sale 18 Mar 2020
Value US$53,250.00 | Price 3.55 | Shares 15,000
Planned sale 17 Mar 2020
Value US$110,715.00 | Price 3.63 | Shares 30,500
Planned sale 16 Mar 2020
Value US$139,500.00 | Price 3.60 | Shares 38,750
Sale 16 Mar 2020
Value US$13,415.50 | Price 3.50 | Shares 3,833
Planned sale 3 Feb 2020
Value US$42,480.00 | Price 5.31 | Shares 8,000
Planned sale 3 Feb 2020
Value US$164,346.00 | Price 5.16 | Shares 31,850
Planned sale 31 Jan 2020
Value US$15,747.26 | Price 5.38 | Shares 2,927
Planned sale 21 Jan 2020
Value US$86,550.00 | Price 5.77 | Shares 15,000
Planned sale 16 Jan 2020
Value US$251,267.64 | Price 5.98 | Shares 42,018
Planned sale 7 Jan 2020
Value US$75,444.45 | Price 5.65 | Shares 13,353
Planned sale 6 Jan 2020
Value US$108,624.00 | Price 5.84 | Shares 18,600
Planned sale 3 Jan 2020
Value US$83,142.00 | Price 6.00 | Shares 13,857
Planned sale 2 Jan 2020
Value US$330,017.10 | Price 6.09 | Shares 54,190
Planned sale 2 Jan 2020
Value US$48,800.00 | Price 6.10 | Shares 8,000
Planned sale 26 Dec 2019
Value US$70,000.00 | Price 7.00 | Shares 10,000
Sale 20 Dec 2019
Value US$6,320,000.00 | Price 6.32 | Shares 1,000,000
Sale 18 Dec 2019
Value US$4,875,000.00 | Price 6.50 | Shares 750,000
Sale 18 Dec 2019
Value US$1,610,000.00 | Price 6.44 | Shares 250,000
Sale 11 Dec 2019
Value US$318,000.00 | Price 6.36 | Shares 50,000
Planned sale 2 Dec 2019
Value US$54,880.00 | Price 6.86 | Shares 8,000
Sale 2 Dec 2019
Value US$262,304.02 | Price 6.82 | Shares 38,461
Sale 18 Nov 2019
Value US$8,850,000.00 | Price 5.90 | Shares 1,500,000
Sale 18 Nov 2019
Value US$1,734,165.07 | Price 5.90 | Shares 293,757
Planned sale 18 Nov 2019
Value US$151,500.00 | Price 6.06 | Shares 25,000
Sale 15 Nov 2019
Value US$13,319,088.99 | Price 6.04 | Shares 2,206,243
Sale 15 Nov 2019
Value US$181,634.25 | Price 6.09 | Shares 29,825
Sale 15 Nov 2019
Value US$1,222,000.00 | Price 6.11 | Shares 200,000
Planned sale 1 Nov 2019
Value US$46,640.00 | Price 5.83 | Shares 8,000
Planned sale 28 Oct 2019
Value US$195,000.00 | Price 6.00 | Shares 32,500
Planned sale 18 Oct 2019
Value US$433,774.20 | Price 5.15 | Shares 84,228
Planned sale 17 Oct 2019
Value US$164,079.00 | Price 5.15 | Shares 31,860
Planned sale 16 Oct 2019
Value US$45,896.80 | Price 5.15 | Shares 8,912
Planned sale 15 Oct 2019
Value US$514,538.58 | Price 4.98 | Shares 103,321
Planned sale 15 Oct 2019
Value US$162,500.00 | Price 5.00 | Shares 32,500
Planned sale 1 Oct 2019
Value US$34,720.00 | Price 4.34 | Shares 8,000
Sale 19 Sep 2019
Value US$117,383.74 | Price 4.79 | Shares 24,506
Sale 18 Sep 2019
Value US$208,382.22 | Price 4.77 | Shares 43,686
Sale 17 Sep 2019
Value US$752,877.83 | Price 4.79 | Shares 157,177
Planned sale 3 Sep 2019
Value US$34,320.00 | Price 4.29 | Shares 8,000
Planned sale 1 Aug 2019
Value US$30,560.00 | Price 3.82 | Shares 8,000
Planned sale 1 Jul 2019
Value US$37,440.00 | Price 4.68 | Shares 8,000
Sale 25 Jun 2019
Value US$398,199.34 | Price 4.39 | Shares 90,706
Planned sale 12 Jun 2019
Value US$747,253.95 | Price 4.21 | Shares 177,495
Planned sale 11 Jun 2019
Value US$1,296,624.54 | Price 4.22 | Shares 307,257
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-02-08 2022-02-04 PlS Planned sale
2.8
Vollins James

See Remarks

Officer
4,763 +33.3%
263.22
US$1,900,903 		4,763 +33.3% 263.22 US$1,900,903
2021-12-06 2021-12-02 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
8,389 +12.1%
433.45
US$4,235,630 		8,389 +12.1% 433.45 US$4,235,630
2021-11-22 2021-11-19 B Purchase
3.3
KOTLER KEVIN
Non-Executive Director
85,847 +11.9%
54.77
US$3,968,026 		85,847 +11.9% 54.77 US$3,968,026
2021-11-15 2021-11-12 B Purchase
3.3
KOTLER KEVIN
Non-Executive Director
100,000 +2.0%
3.20
US$320,000 		100,000 +2.0% 3.20 US$320,000
2021-11-12 2021-11-11 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
16,000 +1.4%
3.20
US$51,200 		16,000 +1.4% 3.20 US$51,200
2021-11-09 2021-11-05 B Purchase
3.3
KOTLER KEVIN
Non-Executive Director
257,800 +5.5%
3.47
US$894,566 		257,800 +5.5% 3.47 US$894,566
2021-05-13 2021-05-13 B Purchase
3.3
KOTLER KEVIN
Non-Executive Director
50,000 +1.1%
3.25
US$162,500 		50,000 +1.1% 3.25 US$162,500
2021-05-13 2021-05-13 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
3,000 +0.3%
3.16
US$9,480 		3,000 +0.3% 3.16 US$9,480
2021-05-13 2021-05-12 B Purchase
3.3
KOTLER KEVIN
Non-Executive Director
100,000 +2.2%
3.24
US$324,000 		100,000 +2.2% 3.24 US$324,000
2021-05-13 2021-05-12 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
5,000 +0.5%
3.24
US$16,200 		5,000 +0.5% 3.24 US$16,200
2021-05-13 2021-05-11 B Purchase
3.3
KOTLER KEVIN
Non-Executive Director
150,000 +3.4%
3.16
US$474,000 		150,000 +3.4% 3.16 US$474,000
2021-05-13 2021-05-11 B Purchase
3.6
Sirgo Mark A
Non-Executive Director
7,500 +0.7%
3.16
US$23,700 		7,500 +0.7% 3.16 US$23,700
2021-02-08 2021-02-08 PlS Planned sale
2.8
Vollins James

See Remarks

Officer
3,833 -100.0%
4.16
US$15,945 		3,833 -100.0% 4.16 US$15,945
2021-02-08 2021-02-04 PlS Planned sale
2.8
Vollins James

See Remarks

Officer
8,303 -68.4%
3.97
US$32,963 		8,303 -68.4% 3.97 US$32,963
2021-02-02 2021-02-01 PlS Planned sale
3.8
Coelho Mary Theresa

See Remarks

Officer
3,460 -10.2%
3.87
US$13,390 		3,460 -10.2% 3.87 US$13,390
2021-01-20 2021-01-19 PlS Planned sale
3.8
Coelho Mary Theresa

See Remarks

Officer
6,462 -21.3%
4.32
US$27,916 		6,462 -21.3% 4.32 US$27,916
2020-12-16 2020-12-16 S Sale
2.8
Vollins James

See Remarks

Officer
9,505 -100.0%
4.48
US$42,582 		9,505 -100.0% 4.48 US$42,582
2020-12-16 2020-12-15 S Sale
3.3
Bailey Jeffrey Allen

Chief Executive Officer

Executive Director
10,000 -21.9%
4.35
US$43,500 		10,000 -21.9% 4.35 US$43,500
2020-12-16 2020-12-14 S Sale
2.8
Vollins James

See Remarks

Officer
20,320 -100.0%
4.46
US$90,627 		20,320 -100.0% 4.46 US$90,627
2020-08-20 2020-08-18 S Sale
4.0
Davis Todd C
Non-Executive Director
50,000 -18.7%
4.99
US$249,500 		50,000 -18.7% 4.99 US$249,500
2020-08-19 2020-08-17 S Sale
3.9
Watson W. Mark
Non-Executive Director
13,000 -19.7%
5.18
US$67,340 		13,000 -19.7% 5.18 US$67,340
2020-08-17 2020-08-14 S Sale
3.6
Sirgo Mark A
Non-Executive Director
115,000 -9.5%
4.90
US$563,500 		115,000 -9.5% 4.90 US$563,500
2020-08-17 2020-08-13 S Sale
3.6
Sirgo Mark A
Non-Executive Director
85,000 -6.6%
4.53
US$385,050 		85,000 -6.6% 4.53 US$385,050
2020-05-22 2020-05-21 S Sale
2.8
Vollins James

See Remarks

Officer
21,666 -100.0%
4.60
US$99,664 		21,666 -100.0% 4.60 US$99,664
2020-05-20 2020-05-18 PlS Planned sale
Plesha Scott M.

See Remarks

Officer
15,000 -6.0%
4.52
US$67,800 		15,000 -6.0% 4.52 US$67,800
2020-05-12 2020-05-08 PlS Planned sale
3.6
Sirgo Mark A
Non-Executive Director
100,000 -7.3%
5.07
US$507,000 		100,000 -7.3% 5.07 US$507,000
2020-05-08 2020-05-06 PlS Planned sale
ODONNELL FRANCIS E JR
Non-Executive Director
11,250 -1.8%
4.53
US$50,962 		11,250 -1.8% 4.53 US$50,962
2020-05-05 2020-05-04 PlS Planned sale
ODONNELL FRANCIS E JR
Non-Executive Director
16,000 -2.5%
4.45
US$71,200 		16,000 -2.5% 4.45 US$71,200
2020-04-29 2020-04-27 PlS Planned sale
3.6
Sirgo Mark A
Non-Executive Director
100,000 -6.8%
4.58
US$458,000 		100,000 -6.8% 4.58 US$458,000
2020-04-22 2020-04-20 PlS Planned sale
ODONNELL FRANCIS E JR
Non-Executive Director
20,000 -3.1%
4.22
US$84,400 		20,000 -3.1% 4.22 US$84,400
2020-04-17 2020-04-15 PlS Planned sale
3.6
Sirgo Mark A
Non-Executive Director
50,000 -3.3%
4.13
US$206,500 		50,000 -3.3% 4.13 US$206,500
2020-03-18 2020-03-18 PlS Planned sale
Plesha Scott M.

See Remarks

Officer
15,000 -5.7%
3.55
US$53,250 		15,000 -5.7% 3.55 US$53,250
2020-03-18 2020-03-17 PlS Planned sale
ODONNELL FRANCIS E JR
Non-Executive Director
30,500 -4.4%
3.63
US$110,715 		30,500 -4.4% 3.63 US$110,715
2020-03-18 2020-03-16 PlS Planned sale
ODONNELL FRANCIS E JR
Non-Executive Director
38,750 -5.3%
3.60
US$139,500 		38,750 -5.3% 3.60 US$139,500
2020-03-18 2020-03-16 S Sale
2.8
Vollins James

See Remarks

Officer
3,833 -100.0%
3.50
US$13,416 		3,833 -100.0% 3.50 US$13,416
2020-02-04 2020-02-03 PlS Planned sale
ODONNELL FRANCIS E JR
Non-Executive Director
8,000 -1.4%
5.31
US$42,480 		8,000 -1.4% 5.31 US$42,480
2020-02-04 2020-02-03 PlS Planned sale
Cukier Herm

Chief Executive Officer

Executive Director
31,850 -47.1%
5.16
US$164,346 		31,850 -47.1% 5.16 US$164,346
2020-02-04 2020-01-31 PlS Planned sale
2.5
Smith Thomas B

Chief Medical Officer

Officer
2,927 -38.2%
5.38
US$15,747 		2,927 -38.2% 5.38 US$15,747
2020-01-23 2020-01-21 PlS Planned sale
Plesha Scott M.

See Remarks

Officer
15,000 -7.2%
5.77
US$86,550 		15,000 -7.2% 5.77 US$86,550
2020-01-17 2020-01-16 PlS Planned sale
3.8
Coelho Mary Theresa

See Remarks

Officer
42,018 -77.8%
5.98
US$251,268 		42,018 -77.8% 5.98 US$251,268
2020-01-09 2020-01-07 PlS Planned sale
3.6
Sirgo Mark A
Non-Executive Director
13,353 -0.9%
5.65
US$75,444 		13,353 -0.9% 5.65 US$75,444
2020-01-06 2020-01-06 PlS Planned sale
3.6
Sirgo Mark A
Non-Executive Director
18,600 -1.2%
5.84
US$108,624 		18,600 -1.2% 5.84 US$108,624
2020-01-06 2020-01-03 PlS Planned sale
3.6
Sirgo Mark A
Non-Executive Director
13,857 -0.9%
6.00
US$83,142 		13,857 -0.9% 6.00 US$83,142
2020-01-06 2020-01-02 PlS Planned sale
3.6
Sirgo Mark A
Non-Executive Director
54,190 -3.4%
6.09
US$330,017 		54,190 -3.4% 6.09 US$330,017
2020-01-03 2020-01-02 PlS Planned sale
ODONNELL FRANCIS E JR
Non-Executive Director
8,000 -1.4%
6.10
US$48,800 		8,000 -1.4% 6.10 US$48,800
2019-12-30 2019-12-26 PlS Planned sale ODONNELL FRANCIS E JR Non-Executive Director
10,000 -1.8%
7.00
US$70,000 		10,000 -1.8% 7.00 US$70,000
2019-12-20 2019-12-20 S Sale Broadfin Healthcare Master Fund Ltd Non-Executive Director
1,000,000 -30.3%
6.32
US$6,320,000 		1,000,000 -30.3% 6.32 US$6,320,000
2019-12-20 2019-12-18 S Sale Broadfin Healthcare Master Fund Ltd Non-Executive Director
750,000 -18.5%
6.50
US$4,875,000 		750,000 -18.5% 6.50 US$4,875,000
2019-12-20 2019-12-18 S Sale Broadfin Healthcare Master Fund Ltd Non-Executive Director
250,000 -5.8%
6.44
US$1,610,000 		250,000 -5.8% 6.44 US$1,610,000
2019-12-13 2019-12-11 S Sale Plesha Scott M.

See Remarks

Officer
50,000 -19.4%
6.36
US$318,000 		50,000 -19.4% 6.36 US$318,000
2019-12-04 2019-12-02 PlS Planned sale ODONNELL FRANCIS E JR Non-Executive Director
8,000 -1.4%
6.86
US$54,880 		8,000 -1.4% 6.86 US$54,880
2019-12-04 2019-12-02 S Sale Cukier Herm

Chief Executive Officer

Executive Director
38,461 -51.4%
6.82
US$262,304 		38,461 -51.4% 6.82 US$262,304
2019-11-19 2019-11-18 S Sale Broadfin Healthcare Master Fund Ltd Non-Executive Director
1,500,000 -83.3%
5.90
US$8,850,000 		1,500,000 -83.3% 5.90 US$8,850,000
2019-11-19 2019-11-18 S Sale Broadfin Healthcare Master Fund Ltd Non-Executive Director
293,757 -14.0%
5.90
US$1,734,165 		293,757 -14.0% 5.90 US$1,734,165
2019-11-19 2019-11-18 PlS Planned sale Plesha Scott M.

See Remarks

Officer
25,000 -8.9%
6.06
US$151,500 		25,000 -8.9% 6.06 US$151,500
2019-11-19 2019-11-15 S Sale Broadfin Healthcare Master Fund Ltd Non-Executive Director
2,206,243 -51.3%
6.04
US$13,319,089 		2,206,243 -51.3% 6.04 US$13,319,089
2019-11-19 2019-11-15 S Sale Vollins James

See Remarks

Officer
29,825 -100.0%
6.09
US$181,634 		29,825 -100.0% 6.09 US$181,634
2019-11-19 2019-11-15 S Sale Davis Todd C Non-Executive Director
200,000 -45.7%
6.11
US$1,222,000 		200,000 -45.7% 6.11 US$1,222,000
2019-11-05 2019-11-01 PlS Planned sale
ODONNELL FRANCIS E JR
8,000 -1.4%
5.83
US$46,640 		8,000 -1.4% 5.83 US$46,640
2019-10-30 2019-10-28 PlS Planned sale
ODONNELL FRANCIS E JR
32,500 -5.3%
6.00
US$195,000 		32,500 -5.3% 6.00 US$195,000
2019-10-22 2019-10-18 PlS Planned sale
3.6
Sirgo Mark A
84,228 -5.1%
5.15
US$433,774 		84,228 -5.1% 5.15 US$433,774
2019-10-17 2019-10-17 PlS Planned sale
3.6
Sirgo Mark A
31,860 -1.9%
5.15
US$164,079 		31,860 -1.9% 5.15 US$164,079
2019-10-17 2019-10-16 PlS Planned sale
3.6
Sirgo Mark A
8,912 -0.5%
5.15
US$45,897 		8,912 -0.5% 5.15 US$45,897
2019-10-17 2019-10-15 PlS Planned sale
3.6
Sirgo Mark A
103,321 -5.7%
4.98
US$514,539 		103,321 -5.7% 4.98 US$514,539
2019-10-17 2019-10-15 PlS Planned sale
ODONNELL FRANCIS E JR
32,500 -5.3%
5.00
US$162,500 		32,500 -5.3% 5.00 US$162,500
2019-10-03 2019-10-01 PlS Planned sale
ODONNELL FRANCIS E JR
8,000 -1.4%
4.34
US$34,720 		8,000 -1.4% 4.34 US$34,720
2019-09-19 2019-09-19 S Sale
3.6
Sirgo Mark A
24,506 -1.3%
4.79
US$117,384 		24,506 -1.3% 4.79 US$117,384
2019-09-19 2019-09-18 S Sale
3.6
Sirgo Mark A
43,686 -2.3%
4.77
US$208,382 		43,686 -2.3% 4.77 US$208,382
2019-09-19 2019-09-17 S Sale
3.6
Sirgo Mark A
157,177 -7.7%
4.79
US$752,878 		157,177 -7.7% 4.79 US$752,878
2019-09-04 2019-09-03 PlS Planned sale
ODONNELL FRANCIS E JR
8,000 -1.3%
4.29
US$34,320 		8,000 -1.3% 4.29 US$34,320
2019-08-02 2019-08-01 PlS Planned sale ODONNELL FRANCIS E JR Non-Executive Director
8,000 -1.3%
3.82
US$30,560 		8,000 -1.3% 3.82 US$30,560
2019-07-03 2019-07-01 PlS Planned sale
ODONNELL FRANCIS E JR
8,000 -1.3%
4.68
US$37,440 		8,000 -1.3% 4.68 US$37,440
2019-06-27 2019-06-25 S Sale
3.6
Sirgo Mark A
90,706 -4.3%
4.39
US$398,199 		90,706 -4.3% 4.39 US$398,199
2019-06-13 2019-06-12 PlS Planned sale
3.6
Sirgo Mark A
177,495 -7.7%
4.21
US$747,254 		177,495 -7.7% 4.21 US$747,254
2019-06-13 2019-06-11 PlS Planned sale
3.6
Sirgo Mark A
307,257 -11.8%
4.22
US$1,296,625 		307,257 -11.8% 4.22 US$1,296,625
Explore more

More insider trading research around BioDelivery Sciences International Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America